InVivo Therapeutics Corpの簿価
InVivo Therapeutics Corpの簿価 は何ですか。
InVivo Therapeutics Holdings Corpの簿価 は1.44です。
簿価 の定義は何ですか。
1株当たりの帳簿価額は、会社の資産から会社の負債を差し引いた数を発行済株式数で割ったものです。
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
NASDAQのセクタHealth Careにおける簿価 の企業と比べるInVivo Therapeutics Corp
InVivo Therapeutics Corpは何をしますか。
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
InVivo Therapeutics Corpと類似の簿価
- Extendicareの簿価 は1.43です。
- Solitonの簿価 は1.43です。
- Haidilao Internationalの簿価 は1.43です。
- Medalist Diversified REITの簿価 は1.44です。
- Maanshan Iron & Steelの簿価 は1.44です。
- Controladora Vuela Cia De Aviacionの簿価 は1.44です。
- InVivo Therapeutics Corpの簿価 は1.44です。
- NeuBase Therapeuticsの簿価 は1.44です。
- CR Constructionの簿価 は1.44です。
- Excellon Resourcesの簿価 は1.44です。
- DPA NVの簿価 は1.44です。
- DPA N.Vの簿価 は1.44です。
- TELUS International (Cda)の簿価 は1.44です。